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16S rRNA sequencingAbstract The main objective of this study was to evaluate the antimicrobial activity and anti-
inﬂammatory activity of marine actinomycetes extract against ocular pathogen Pseudomonas aerug-
inosa. Actinomycetes isolated from Rameswaram coastal region, Tamilnadu, India were initially
screened by primary screening and secondary screening against ocular pathogen P. aeruginosa. Fol-
lowed by anti-conjunctivitis efﬁcacy of actinomycetes ethyl acetate extract formulation versus cipro-
ﬂoxacin ophthalmic solution was evaluated using rabbit as animal model. The bioactive compounds
present in the best actinomycetes extract was identiﬁed by HPTLC and GC–MS analysis. Finally
the screened best actinomycetes was identiﬁed by 16S rRNA sequencing method. In primary screen-
ing 28 actinomycetes that inhibited the growth of P. aeruginosa were taken for secondary screening.
In secondary screening RAM24C2 extract had maximum activity against P. aeruginosa. In vivo
study of conjunctivitis developed rabbits treated with RAM24C2 extract formulation showed the
best clinical cure than ciproﬂoxacin ophthalmic solution. The RAM24C2 extract was chromato-
graphically characterized and found to contain macrolides. In addition, the effective major pivotal
molecule in the extract was detected as 1, 2 benzene dicarboxylic acid and Bis (2-ethylhexyl) phtha-
late by GC–MS analysis. The RAM24C2 strain was identiﬁed as Streptomyces sp. MAD01 and the
sequence was submitted in NCBI with accession number JX050218. From our study it is found that
the ethyl acetate extract obtained from marine actinomycetes is effective against ocular pathogenahar@
Comparative efﬁcacy of macrolides containing marine actinomycetes 27P. aeruginosa. Compared to ciproﬂoxacin ophthalmic solution our RAM24C2 extract formulation
hastens the cure of conjunctivitis developed rabbits and need less dosage frequency.
 2015 Faculty ofVeterinaryMedicine,CairoUniversity. Production andhostingbyElsevierB.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Conjunctivitis is a prevalent disease all over the world espe-
cially higher rate of infection was found in developing coun-
tries. Every people at least once in their lifetime gets affected
by conjunctivitis. Conjunctivitis commonly described by red
eye which shows symptoms like conjunctival congestion, eyelid
edema, irritation in eye with discharge, sometimes in the morn-
ing difﬁcult to open the eye due to sticking of the eyelid
together by discharge. Conjunctiva is a mucous membrane
which covers the bulbar conjunctiva and palpebral conjunctiva
and safeguard the eye against invading microorganisms. Con-
junctivitis caused by various external factors like bacteria,
virus and fungi. Among these 80% of conjunctivitis occurred
by bacteria [1]. Among the different bacteria Pseudomonas
aeruginosa is one of the common pathogen causing conjunc-
tivitis with severe infection including capable of producing dif-
ferent toxins and proteases thereby damages ocular tissues [2].
There are many topical antibiotics are available to cure for
P. aeruginosa conjunctivitis. Fluoroquinolones like ciproﬂoxa-
cin, oﬂoxacin, levoﬂoxacin and aminoglycosides like tobramy-
cin, gentamicin and some other antibiotics like polymyxin B
and neomycin are used as ophthalmic eye drops in different
concentration. These topical antibiotics possessed broad spec-
trum activity as antimicrobial agents. But the resistance prob-
lem of ophthalmic pathogens, side effects and expensive of
antibiotics making the researchers to search for new antibiotics
as ophthalmic solution. Especially P. aeruginosa highly resis-
tant to most of the antibiotics [3,4].
In this regard here we have taken marine actinomycetes for
our research purpose. Because marine actinomycetes reveals as
source of natural products for human ailments. Marine actino-
mycetes exhibit different biological activity especially broad
spectrum activity against gram positive and gram negative bac-
teria. Among marine actinomycetes, Streptomyces are the chief
producer of novel antibiotics. Each day many new antibiotics
are identiﬁed from actinomycetes. Among actinomycetes 80%
of antibiotics were derived from Streptomyces family [5,6].
The present study was carried out to evaluate the biological
activity (anti-conunctivitis) of actinomycetes isolated from
marine coastal regions of Rameswaram, Tamilnadu, India.
Their potential to control ocular pathogen P. aeruginosa both
in vitro and in vivo animal model was analyzed. The efﬁcacy of
actinomycetes extract formulation, with available quinolone
ophthalmic solution ciproﬂoxacin was also compared.2. Materials and methods
2.1. Isolation and identification of Actinomycetes
Marine soil samples were collected from coastal regions of
Rameswaram, Tamilnadu, India. Selective isolation of actino-
mycetes from soil samples was carried out by spread platetechnique using Actinomycetes isolation agar medium. The
isolation medium was supplemented with 0.2 mg/ml ﬂucona-
zole [7] and 20 mg/l nalidixic [8] to inhibit fungal and bacterial
colonization respectively. After incubation, actinomycetes
colonies appeared on the agar medium were pure cultured by
restreaking in the same agar medium and used for further
assays.
2.2. Bacterial culture
The authenticated ophthalmic pathogen P. aeruginosa
obtained from Aravind eye Hospital, Coimbatore, Tamilnadu,
India. The pathogen was isolated form clinical specimen in
Clinical Microbiology laboratory of the hospital.
2.3. Antibiotic susceptibility of the test organism
The antibiogram pattern of the ophthalmic pathogen
P. aeruginosa was checked against the commercially available
antibiotic discs (Himedia) using the standard disc diffusion test
[9]. The log phase culture broth was seeded in Muller Hinton
agar plate by sterile swab. The antibiotics discs with the fol-
lowing concentrations were placed in equidistant with uniform
contact between the antibiotic discs and the surface of the
Muller Hinton agar plates, Amoxyclav (30 mcg), Ceftazidime
(30 mcg), Chloramphenicol (30 mcg), Gentamicin (10 mcg),
Nalidixic acid (30 mcg), Nitrofurantoin (30 mcg), Norﬂoxacin
(10 mcg), Tetracycline (30 mcg), Kanamycin (30 mcg), Imipe-
nem (15 mcg), Ampicillin (15 mcg) and Ciproﬂoxacin
(15 mcg). The plates were then incubated at 37 C in upright
position for overnight. Inhibition zone diameters were mea-
sured and tabulated.
2.4. Screening of actinomycetes for antimicrobial activity
The primary screening of all 131 actinomycetes isolates were
done by streaking perpendicular to the ophthalmic pathogen
P. aeruginosa with four isolates streaked parallel per pet-
ridishes. The zones of inhibition were measured and tabulated
[10]. The actinomycetes isolates that which exhibited good
antibiosis effect against P. aeruginosa were pure cultured
respectively in culture ﬂask. The culture was extracted by sol-
vent extraction method [11] using ethyl acetate as solvent. The
actinomycetes culture extracts were secondary screened for
their antagonistic activity against ophthalmic pathogen. The
secondary screening was done by well diffusion method.
2.5. Determination of stability and shelf life of RAM24C2 ethyl
acetate extract
The best actinomycetes culture extract that had maximum
antagonistic activity against ophthalmic pathogen was sub-
jected for stability and shelf life test. The extract was aliquot
Table 1 Scoring of ocular inﬂammation based on conjunc-
tivitis symptoms.
S.
No.
Observations Scoring of ocular inﬂammation Scores
1. Mucopurulent
Discharge
No discharge 0
Minimal discharge 1
Sticking of the eyelids with
discharge
2
Hair around the eye wetted with
discharge and surrounding skin
area inﬂammation
3
2. Chemosis No chemosis 0
Minimal edema of the conjunctiva 1
Obvious conjunctival edema with
eversion of eyelids
2
Conjunctival edema clearly visible
even without eversion of eyelids
3
3. Conjunctival
congestion
No congestion 0
Minimal congestion 1
Bright red conjunctiva 2
Beefy red conjunctiva 3
5. Palpebral
ﬁssure
Absent 0
Mild (lids are little puﬀy) 1
Moderate (swelling of upper and
lower eyelid)
2
Severe (eyelids are swollen) 3
28 F. Wahaab et al.into 7 screw cap vials with 5 ml each. These tubes were respec-
tively incubated for an hour at different temperatures (20 C,
8 C, 30 C, 40 C, 50 C, 60 C and 70 C) maintained in deep
freezer, fridge and in a water baths respectively. After incuba-
tion period the extracts were checked for their antagonistic
activity by well diffusion method. Similarly, for the shelf life
expectancy study 2 sets of 6 aliquots of 5 ml extract in vials
were stored respectively in refrigerated condition (8 C) and
at ambient temperature (30 C). Each aliquot was checked
for its antagonistic activities at every 15 days’ time interval
starting from 0th day to 75th day [12].
2.6. Actinomycetes extract preparation
The marine actinomycetes isolates were inoculated in 50 ml of
ISP2 broth and incubated at 30 C, 150 rpm in orbital shak-
ing incubator for two days. After incubation period 20 ml of
the actinomycetes cultures were inoculated in 300 ml of ISP2
broth in shake ﬂask and incubated at 30 C in an orbitary
shaker at 150 rpm for 7 days. The grown culture was cen-
trifuged and the culture ﬁltrate was subjected for solvent
extraction for recovery of secondary metabolites. The solvent
ethyl acetate was added to the ﬁltrate in the ratio of 1:1 (v/v)
and shaken vigorously for complete extraction. Two layers
aqueous and the organic layer were separated, the solvent
ethyl acetate layer was collected and aqueous layer was dis-
carded. Extraction was continued up to three times with
the same solvent and the solvent layer was accumulated
and concentrated by rotary vacuum evaporator. The residue
is weighed and resuspended in buffer, this was used as
ophthalmic suspension [6].
2.7. In vivo animal model
To analyse the anti-inﬂammatory efﬁciency of the actino-
mycete extract the anticonjunctivitis study was done in the
eye balls of young New Zealand albino male rabbits, weighing
between 2 and 2.5 kg. The conjunctivitis animal model studies
experimental protocol was subjected to Institutional animal
ethical committee and obtained certiﬁcate No (IAEC/KU/
BT/13/10). The designed study has 4 groups with 2 animals
in each group and used both eyes of each animal. From the
acclimatized ten rabbits housed for study two were caged unin-
fected and named group I (uninfected). Both eyeballs of other
eight animals were individually infected with the log phase cul-
ture of clinical isolate P. aeruginosa log phase culture. Holding
the animal at ease the lower eyelid were gently made as cavity
into which 50 ll of 8 h old log phase culture of P. aeruginosa
containing approximately 100 CFU/ml was instilled and
holded for few seconds and ensured the culture spreaded on
the entire eyeball and not spilled out.
After 24 h the 8 infected rabbits eyeball were examined, six
animals who’s both eyeballs have inﬂammated (with reddening)
were chosen and randomized into 3 groups [13].
Group II: treated with normal sterile saline (Negative con-
trol/untreated group).
Group III: treated with commercial eye drop containing
(0.3% W/V) ciproﬂoxacin (Positive control).
Group IV: treated with actinomycete extract resuspended in
saline (Test group).Treatment was initiated from 2nd day that is after this
infection development (Day 2).
From day 2 to day 6 all these 3 groups received treatment
respectively with 50 ll/eyeball. Before administration of drug
the rabbit’s eyeballs were observed daily for ocular inﬂamma-
tion. Scoring was done by observing the curing and symptoms
like mucopurulent discharge, chemosis, conjunctival conges-
tion and palpebral ﬁssure (Table 1).
2.8. Statistical analysis
The ophthalmic scores were expressed as Mean ± SD.
The data was evaluated by one way ANOVA followed by
Dunnett’s T-Test for comparison of multiple variations
using SPSS/16 software. The values *P< 0.05 and **P< 0.01
were considered as signiﬁcant.
2.9. GC–MS and HPTLC analysis
The RAM24C2 ethyl acetate extract was checked for bioactive
compounds by GC–MS analysis and HPTLC proﬁle analysis
for macrolides, quinolones and terpenoids. The Gas
Chromatography and Mass Spectrometry was analysed by
GC–MS electron impact ionization (EI) method on GC-8000
gas chromatograph (FISONS Instruments) coupled to a
MD-800 Mass Spectrometer (FISONS Instruments).
Compound identiﬁcation was done by comparing the NIST
(National Institute of Standards and Technology-Chemistry
web book by WILEY) library data of the peaks with those
reported in literature. The HPTLC analysis was performed
using Hamilton syringe and CAMAG LINOMAT 5
instrument, CAMAG REPROSTAR 3 photo-documentation
chamber and CAMAG TLC SCANNER 3.
Table 2 Antibiotic susceptibility testing of ocular pathogen
Pseudomonas aeruginosa.
Antibiotics Zone of inhibition (mm) Susceptibility
Amoxyclav 0 Resistant
Ampicillin 0 Resistant
Ceftazidime 16 Intermediate
Chloramphenicol 17 Intermediate
Gentamicin 10 Intermediate
Nalidixic acid 15 Intermediate
Nitrofurantoin 0 Resistant
Norﬂoxacin 25 Resistant
Tetracycline 0 Resistant
Kanamycin 0 Resistant
Ciproﬂoxacin 23 Sensitive
Imipenem 26 Sensitive
Comparative efﬁcacy of macrolides containing marine actinomycetes 292.10. Strain identification at molecular level
16S rRNA analysis was performed for RAM24C2 isolate. The
actinomycete genomic DNA was isolated using commercial kit
then run in Applied biosystem veriti 96well thermo cycler PCR
machine. Finally, the sequencing done in ABI 3730XL Genetic
Analyser with sequence scanner V1.0 applied biosystem (By
Euroﬁns Genomics India PVT. Ltd., India). The sequence of
isolate was compared by alignment against 16S rRNA
sequences, available in the GenBank Database using the
BLAST program. Alignment and similarity comparison were
initially conducted by the Clustal W method [14] and the
phylogenetic tree was constructed using Clustal W with the
neighbour joining method. A boost strap analysis of 1000
replicates was carried out using MEGA 5.05 software.0
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Fig. 1 Determination of shelf life of RAM24C2 ethyl acetate
extract.3. Results
3.1. In vitro antimicrobial activity
Out of 131 actinomycetes isolated from Rameswaram coastal
region, Tamilnadu, India, 28 actinomycetes (21%) were able
to control the growth of gram negative ocular pathogen
P. aeruginosa in primary screening while the remaining 79%
actinomycetes did not exhibit antimicrobial activity against
P. aeruginosa. Based on the primary screening results the 28
active actinomycetes ethyl acetate extracts were prepared and
subjected to secondary screening to evaluate its antimicrobial
activity. Out of 28 actinomycetes four actinomycetes ethyl
acetate extracts displayed maximum antimicrobial activity.
Among the four actinomycetes extracts, the highest antimicro-
bial activity against P. aeruginosa was observed in RAM24C2
extract (24 mm) followed by RAM25B4 (16 mm), RAM23C1
(14 mm) and RAM25C4 (14 mm). The isolate RAM24C2
which highly active against ocular pathogen in vitro was taken
for next study.
3.2. Antibiotic susceptibility testing of P. aeruginosa
The ophthalmic clinical isolate P. aeruginosa was evaluated for
its antibiotic susceptibility pattern against twelve antibiotics.
P. aeruginosa was highly sensitive to imipenem with a zone
of inhibition 26 mm followed by ciproﬂoxacin (23 mm). But
it was resistant to many antibiotics tested like nitrofurantoin,
norﬂoxacin, amoxyclav, ampicillin, tetracycline and kanamy-
cin. But some antibiotics like, ceftazidime, chloramphenicol,
gentamycin and nalidixic acid showed intermediate response
to the ocular pathogen P. aeruginosa. Our actinomycetes
extract RAM24C2 exhibited better activity than the commer-
cial antibiotics nitrofurantoin, amoxyclav, ampicillin, tetracy-
cline, kanamycin, Ceftazidime, gentamycin and nalidixic
acid. RAM24C2 extract displayed greater activity than cipro-
ﬂoxacin and activity equivalent with imipenem antibiotic
(Table 2).
3.3. Determination of thermal inactivation point of RAM24C2
ethyl acetate extract
The RAM24C2 ethyl acetate extract retained its antimicrobial
activity against P. aeruginosa up to 40 C. The optimumtemperature for storage was observed between 20 C and
30 C. But at 40 C reduction in the antimicrobial activity
was observed up to 50%. The extract had no activity above
40 C (Fig. 1).
3.4. Shelf life of RAM24C2 ethyl acetate extract
The RAM24C2 ethyl acetate extract withhold its antimicrobial
activity for the whole testing period (75 days at 8 C). So we
can infer that the extract was stable at 8 C for the entire test-
ing period. But the extract stored at 30 C withhold its activity
for 30 days. The extract stored at 30 C after 30 days exhibited
loss of antimicrobial activity against P. aeruginosa (Fig. 2).
3.5. Anti-inflammatory activity of RAM24C2 ethyl acetate
extract formulation
On the second day after infection with P. aeruginosa the rab-
bit’s eyeballs developed beefy red conjunctiva, mucopurulent
discharge, palpebral ﬁssure and chemosis. There was no much
difference observed among the group II, III and IV on the sec-
ond day after infection (Fig. 3). The infection was severe in
rabbits especially in the conjunctival congestion but the symp-
tom like mucopurulent discharge formation was less. The
treatment was started from the second day onwards. The
RAM24C2 extract formulation was effective in controlling
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Fig. 2 Thermal stability of RAM24C2 ethyl acetate extract.
Fig. 4 Clinical score of inﬂammation and anti-inﬂammatory
effect of RAM24C2 extract formulation versus ciproﬂoxacin
ophthalmic solution in Staphylococcus aureus induced conjunc-
tivitis. Values are Mean ± SD; (n= 4), *P< 0.05, **P< 0.010.
30 F. Wahaab et al.P. aeruginosa induced conjunctivitis while compared to cipro-
ﬂoxacin ophthalmic solution.
Based on the clinical score results (Fig. 4) we infer that after
ﬁrst day of treatment (day 3) the mucopurulent discharge was
reduced between treated groups. But there is no reduction in
other symptoms like chemosis, palpebral ﬁssure and conjuncti-
val congestion in treated groups. After, two days of treatment
(day 4) signiﬁcant reduction in inﬂammation was observed in
treatment groups. In ciproﬂoxacin treated group the mucopu-
rulent discharge formation was less; the beefy red conjunctiva
changed to bright red conjunctiva, showed obvious conjuncti-
val edema with eversion of eyelid and palpebral ﬁssure was in
moderate level. Whereas in RAM24C2 formulation treated
group the mucopurulent discharge formation was absent,
showed minimal congestion, palpebral ﬁssure was moderate
and minimal edema of the conjunctiva was observed. While
comparing to ciproﬂoxacin treated group, the RAM24C2 for-
mulation treated group showed effective clinical cure after
2 days of treatment itself (4th day). After three days of treat-
ment (day 5), the ciproﬂoxacin treated group showed absence
of mucopurulent discharge, minimal congestion, mild palpe-
bral ﬁssure and minimal edema of the conjunctiva whereas
RAM24C2 formulation treated group minimal edema of the
conjunctiva and mild palpebral ﬁssure observed. After four
days of treatment (day 6) the complete clinical cure was
observed in the RAM24C2 formulation treated group whereas
in ciproﬂoxacin treated group mild palpebral ﬁssure observed
(Fig. 5).
From our study results for comparing the efﬁcacy of the
curing of bacterial conjunctivitis using RAM24C2 extract for-
mulation in comparison with standard drug ciproﬂoxacin; it is
observed that 50 ll actinomycetes formulation (RAM24C2)
administered twice daily for four days after infection maybe
efﬁcacious in the complete treatment of P. aeruginosa induced
conjunctivitis. While the same dosage of ciproﬂoxacin treated
group, the inﬂammation subsidized only after ﬁve days ofFig. 3 Pseudomonas aeruginosa induced ctreatment. In the actinomycetes formulation treated group
the mucopurulent discharge disappeared even in the 1st day
of treatment itself.
3.6. HPTLC and GC–MS analysis of RAM24C2 extract
The ethyl acetate extract of RAM24C2 strain checked for
macrolides (erythromycin), terpenoids (solanesol) and quino-
lone (nalidixic acid) proﬁle by HPTLC. Brown and brownish
violet colour zones at UV 366 nm was present in the standard
track and the RAM24C2 ethyl acetate extract track, it was
observed from the chromatogram after derivatization which
conﬁrmed the presence of macrolide in the standard track
and also in the ethyl acetate extract track (Figs. 6 and 7,
Table 3). But terpenoids and quinolones were absent in the
extract.
In GC–MS analysis 14 compounds were observed (Fig. 8).
The compound name with molecular weight, molecular for-
mula, retension time and area percentage were tabulated
(Table 4). The major constituents are 1, 2 benzene dicarboxylic
acid and Bis (2-ethylhexyl) phthalate (44.67%). The structure
of major compounds were shown in Fig. 9. There are many
pivotal molecules were present in the RAM24C2 extract. Fatty
acid compounds, aromatic compounds which plays a major
role as antimicrobial agents were present in the extract.
3.7. Molecular identification of RAM24C2 actinomycete
The BLAST analysis of the 16S rRNA gene sequence of the
RAM24C2 strain compared with the sequences contained inonjunctivitis in different animal groups.
Fig. 5 Stages of curing conjunctivitis in different groups.
Fig. 6 RAM24C2 ethyl acetate extract Macrolide proﬁle in HPTLC analysis. (a and b) Macrolide chromatogram before dervitatization
under day light and UV 366 nm. (c and d) Macrolide chromatogram after dervitatization under day light and UV 366 nm.
Comparative efﬁcacy of macrolides containing marine actinomycetes 31the data bank (GenBank). The Phylogenetic tree was con-
structed with boot strap values using Mega 5.05 software.
Neighbour joining tree based on 16S rRNA gene sequences
showing relationship between the RAM24C2 sequences with
other Streptomyces species. However the RAM24C2 strain
revealed 100% similarity with Streptomyces sp. MAD01
strain (Fig. 10). The sequence of the Streptomyces sp.
MAD01 strain RAM24C2 was submitted in NCBI with
accession number JX050218.
4. Discussion
This study mainly focused on the anti-inﬂammatory activity
of actinomycete extract against P. aeruginosa inducedconjunctivitis in rabbit model. P. aeruginosa cause severe eye
infection which pose a threat in many countries due to its
multidrug resistant ability. Previously aminoglycosides are
used for the treatment of conjunctivitis but the resistance
problem necessities the search for different antibiotics. In this
regard recently many ﬂuoroquinolones are used for bacterial
conjunctivitis [15].
In our study we have compared the antimicrobial activity
of different actinomycetes extracts with commercially avail-
able ciproﬂoxacin antibiotic disc in vitro studies. Followed
by that for the in vivo we have used 0.3% ciproﬂoxacin
(ﬂuoroquinolones) ophthalmic solution as standard to
compare its efﬁcacy with our actinomycete RAM24C2 extract
formulation.
Fig. 7 Peak densitogram display of RAM24C2 ethyl acetate extract showing macrolides proﬁle.
Table 3 Peak table for macrolide proﬁle of RAM24C2
isolate.
Track Peak Rf Height Area Assigned
substance
Standard 1 0.09 596.9 20163.4 Macrolide
standard
Sample
RAM24C2
12 0.84 107.8 4793.2 Macrolide 1
32 F. Wahaab et al.The ethyl acetate extracts of actinomycetes showed
inhibitory activity against P. aeruginosa. The results exhibit
that the actinomycetes producing antimicrobial compounds
as secondary metabolites in the extracellular secretion which
controls the pathogen growth [16]. Especially RAM24C2
extract had greater biological activity (antimicrobial) than
other actinomycetes extracts.Fig. 8 GC–MS chromatogram of ethylWe examined antibiotics susceptibility of P. aeruginosa
towards twelve antibiotics. P. aeruginosa was controlled well
by imipenem. Similar result was observed with our RAM24C2
actinomycete ethyl acetate extract. Our RAM24C2 extract
exhibit signiﬁcant antimicrobial activity against ocular patho-
gen P. aeruginosa in in vitro studies demonstrates that the
RAM24C2 extract have pivotal bioactive molecules which
can control the multidrug resistant Pseudomonas even in lower
concentration. In a previous study with regard antibiotic sus-
ceptibility testing of P. aeruginosa showed 100% resistance
to norﬂoxacin, ampicillin but exhibited high-sensitivity
towards ciproﬂoxacin [17]. Our study also supports the above
result, ciproﬂoxacin controlled the growth of P. aeruginosa
while norﬂoxacin, ampicillin had no inhibitory activity. While
compared to ciproﬂoxacin, RAM24C2 extract exhibited
greater efﬁcacy in controlling the pathogen and this extract
taken for further study for their bioactive compound identiﬁ-
cation and shelf life, stability analysis.acetate extract of RAM24C2 strain.
Table 4 Bioactive compounds of RAM24C2 isolate identiﬁed
by GC–MS analysis.
Retention
time
Compound names Area
percentage
25.43 1,2 Benzene dicarboxylic acid,
dissoctylester
44.67
Bis (2-ethylhexyl) phthalate 44.67
19.33 Decane, 1-iodo 4.52
Tetradecane, 4-ethyl- 4.52
Nanodecane 4.52
18.72 1-Heptadecanamine 6.95
2,2-Bis (4-methyl benzyl)-1-phenyl-3 6.95
1-octadecanamine 6.95
20.55 3 Hepta ﬂuorobutyroxydodecane 4.19
3 Triﬂuoroacetoxy pentadecane 4.19
21.32 Octadecane 5.44
19.48 Eicosane 3.90
Tetradecanoic acid 3.90
17.57 2H-Pyran 2, (3-butynyloxy)tetrahyd 2.09
Comparative efﬁcacy of macrolides containing marine actinomycetes 33In thermal inactivation point studies, RAM24C2 ethyl acet-
ate extract retained its antimicrobial activity up to 40 C and
the extract was stable until 75 days when stored at 8 C. The
active compounds present in the extract may be heat labile
which lost its antimicrobial activity above 40 C. Sweetline
et al. [18] has reported earlier that crude culture ﬁltrate of acti-
nomycete was able to withstand up to 80 C. Depending on the
species of actinomycetes and kind of secondary metabolite in
the extract the thermal inactivation point may differ. For most
of the crude extracts that which had antimicrobial activity the
optimum temperature was found below 300C in earlier reports
[19]. In our study also the optimum temperature for storage
was found between 20 C and 30 C for RAM24C2 extract.
So for the biological control of ocular pathogen P. aeruginosa
by RAM24C2 extract should be stored below 30 C. In
another study it is reported that culture ﬁltrate of Streptomyces
VPTS3-1 had maximum antimicrobial activity when ﬁltrate
stored at 30 C [20].
In our previous studies we observed severe mucopurulent
discharge and bright red conjunctiva in Staphylococcus aureus
infected rabbits. But in the case of P. aeruginosa induced con-
junctivitis the infection was severe with beefy red conjunctiva
but moderate mucopurulent discharge was observed. InFig. 9 Major compounds of RAM24C2 ethyl acetate extract ide
dissoctylester, (b) bis (2-ethylhexyl) phthalateanti-inﬂammatory studies the RAM24C2 extract showed faster
cure than ciproﬂoxacin ophthalmic solution. For the complete
eradication of P. aeruginosa induced conjunctivitis ﬁve days
treatment with ciproﬂoxacin necessary whereas four days
treatment is so efﬁcient for RAM24C2 extract formulation.
In earlier ﬁndings Leibowitz [21] reported that topical applica-
tion of ciproﬂoxacin eradicated all isolated ocular bacterial
pathogens. Our study correlates with a study conducted by
Alex Azuka Ilechie [13] demonstrated that the topical applica-
tion of honey twice daily for four days eradicate the bacterial
conjunctivitis caused by P. aeruginosa.
The outcome of in vivo study demonstrated that the
RAM24C2 extract formulation had greater efﬁcacy for con-
trolling P. aeruginosa induced conjunctivitis which can be used
to treat ophthalmic infection caused by P. aeruginosa.
The macrolides are important antibacterial antibiotics. The
presence of this compound may responsible for the antimicro-
bial activity of the RAM24C2 extract. The mode of action of
the ciproﬂoxacin is DNA synthesis inhibition, ciproﬂoxacin
acts on the DNA gyrase of P. aeruginosa there by inhibits
DNA replication of bacteria and ﬁnally leads to death. Our
RAM24C2 extract formulation contain different bioactive
compounds like macrolides which may interact with toxins
produced by pathogen and thereby subsidize the inﬂammation.
Macrolides also act as bacteriostatic agent. The other bioactive
compounds present in the extract may also control pathogen
[22–25].
In GC–MS analysis 14 mixture of compounds were identi-
ﬁed. Most of the identiﬁed compounds in GC–MS analysis of
RAM24C2 extract reported to have antimicrobial properties.
The major constituent present was 1,2 benzene dicarboxylic
acid, dissoctylester also called phthalic acid an aromatic dicar-
boxylic acid compound reported to have many properties like
antimicrobial, antifouling. The same compound also present in
the extract of Nocardiopsis dassonvilleiMAD08 which reported
to have broad spectrum antimicrobial activity [26,27]. Ter-
tradecaonic acid also called myristic acid a fatty acid com-
pound said to have antimicrobial activity in a study
conducted by Agoramoorthy et al. [28]. Pryan derivatives are
reported to have antimicrobial and anti-inﬂammatory activity
[29]. Hence the above mentioned compounds either individu-
ally or in synergism with other compounds may be responsible
of antimicrobial and anti-inﬂammatory activity of RAM24C2
extract.ntiﬁed by GC–MS analysis. (a) 1,2 benzene dicarboxylic acid,
Fig. 10 Neighbour joining tree based on 16S rRNA gene sequences showing relationship between the RAM24C2 Streptomyces with
other Streptomyces species. The number at the nodes indicates the percent levels of boost strap support based on the analysis of 1000
replicates. The scale bar indicates number of changes per base position.
34 F. Wahaab et al.The 16S rRNA sequencing method, reveals that the
RAM24C2 isolate as Streptomyces sp. MAD01. Till now there
is no report on the anti-conjunctivitis activity of this Strepto-
myces species. Hence we provide the ﬁrst hand information
on report the biological activity (anti-inﬂammatory and
antimicrobial) and bioactive compounds of Streptomyces sp.
MAD01. This will enable researchers to carry out further stud-
ies on the structural elucidation of the bioactive compounds,
clinical trials and different biological activity of the extract
of this potent strain.
5. Conclusion
By selective isolation actinomycetes were isolated and pure cul-
tured from Rameswaram coastal soil samples. The actino-
mycetes were screened for their antibiogram pattern against
ophthalmic pathogen P. aeruginosa obtained from clinical iso-
late in microbiological laboratory of Aravind eye hospital. The
best actinomycetes exerting antimicrobial inhibitory activity
against the ophthalmic pathogen P. aeruginosa was mass culti-
vated in broth and extracted the secondary metabolites in ethyl
acetate by phase separation process. The extracts were checked
for the inhibition activity against ophthalmic pathogen in
in vitro. The Streptomyces sp. MADO1 strain RAM242 was
identiﬁed as an eminently suitable strain for isolating antibi-
otics against multidrug resistant ophthalmic pathogen P.
aeruginosa. The ophthalmic pathogen was cultured and used
to create ophthalmic conjunctivitis in rabbit model. The con-
junctivitis was treated with antibiotic ciproﬂoxacin ophthalmic
solution in comparison with actinomycete ophthalmic suspen-
sion. The actinomycete ophthalmic suspension was found to be
effective in accelerated curing of conjunctivitis. The presence
of macrolides identiﬁed through HPTLC analysis inferred that
the RAM24C2 strain is rich source for antimicrobial proﬁle.
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